The global additives market size was US$ 151.4 billion in 2021. The global additives market is forecast to grow to US$ 219.6 billion by 2030 by registering a compound annual growth rate (CAGR) of 5.1% ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Editor’s note: This is the first article in a two-part series exploring additive manufacturing. The Pentagon has poured unprecedented funds into additive manufacturing as a potential game-changer for ...

Pfizer enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution. Click here to read ...

Additive nanomanufacturing applies 3D printing at the nanoscale, enabling precise fabrication for electronics, energy, ...

A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several ...

Pfizer’s stock rebounded from April lows yet still trades as if COVID and patent cliffs equal business ruin, despite resilient non‑COVID franchises and pipeline optionality. Q3 looked weak, with ...

After beefing up the target of its global cost-savings drive once again, Pfizer is continuing to see its plan through with cuts in numerous countries. Now, hundreds of employees in Switzerland are due ...

Since his postdoctoral days at MIT, Hang Yu, associate professor of materials science and engineering, has been wrestling ...

The therapy YP05002 is part of the GLP-1 agonist class of drugs and is currently in early-stage development. Sign up here. Under the terms of the agreement, YaoPharma will complete the ongoing ...

Shanghai Fosun Pharmaceutical is one of China's largest pharmaceutical companies. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) In its latest agreement with a China ...

This article first appeared on GuruFocus. Pfizer (NYSE:PFE) shares slid about 5% on Tuesday morning after the company lowered its earnings and revenue forecasts for 2026. The pharmaceutical giant now ...